The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 61 | — | 20.1x | Near average | |
Growth | 26 | — | 5.6% | Below average | |
Quality | 15 | -46.0% | 7.6% | Below average | |
Safety | 37 | 7.5x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Nuvalent, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Nuvalent, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Nuvalent stock has experienced volatility in its average target price over the last 30 days; the consensus initially rose by 7.6% to reach $189, before recently retreating by 6.35% to settle at $177. This recent decline coincided with a decrease in the number of analysts contributing to the estimates from 15 to 8, suggesting a reassessment of financial models or the removal of some older estimates from calculations, while a wide price gap remains between the low ($165) and high ($189).
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.